These range from FDA-approved medications, such as GLP-1 receptor agonists (Wegovy, Zepbound) for weight loss, to unregulated compounds with minimal or no human safety data
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
66 KirkpatrickA.HeoJ.AbrolR.GoddardW
Partially because we have so many amazing new treatments that employer plans and private plans want to cover, because they have [the] incredible ability to change peoples lives, but they come with huge price tags
Mens Health APEX MEN'S HEALTH Built for Men, Backed by Science
These FDA-approved (Food and Drug Administration) brand-name medications, such as Ozempic, Wegovy, and Rybelsus, belong to the GLP-1 receptor agonist class